Infrared Laser Therapy Shows Promise in Preventing Dry Macular Degeneration

Researchers at Aalto University have developed an innovative, non-invasive treatment for dry age-related macular degeneration (AMD), a condition that currently lacks effective early-stage interventions. By utilizing precisely controlled near-infrared light, the team aims to gently heat the back of the eye to stimulate the body’s innate cellular repair mechanisms. This approach seeks to address the disease at its onset, potentially preventing the permanent vision loss associated with advanced stages of the condition.

Dry AMD is characterized by the accumulation of fatty protein deposits known as drusen, which occur as cellular protective functions decline with age. These deposits create oxidative stress, leading to protein misfolding and eventual retinal damage. The Aalto University method employs a mild heat-shock response to activate heat shock proteins. These proteins assist in refolding damaged cellular components or facilitating the breakdown of waste, effectively clearing the cellular debris that contributes to the progression of AMD.

The primary challenge in this therapy is maintaining a precise temperature range; exceeding 45 degrees Celsius could cause irreversible tissue damage. To mitigate this risk, the researchers engineered a system capable of real-time temperature monitoring during the application of infrared light. This ensures the treatment remains within a therapeutic window that triggers cellular defense mechanisms without causing thermal injury.

This development represents a significant shift in ophthalmology, moving from reactive treatments to proactive cellular maintenance. By intervening before significant vision loss occurs, this technology could fundamentally change the management of AMD for millions of aging adults. If successful in further clinical trials, this laser-based therapy offers a promising, scalable solution to preserve central vision and improve the quality of life for those at risk of this debilitating disease.